View Central ADN's top competitors like 23andMe Inc, Ambry Genetics, and Clinical Genomics.
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs.
Salt Lake City, Utah, US
Public
$682.4M Revenue
http://www.myriad.com/
2.9K Employees
MYGN Ticker
Our vision: A world where every cancer treatment decision is as personal as the patient.
Our mission: We take cancer personally.
We partner with physicians to deliver actionable insights that guide personalized treatment decisions and improve outcomes -- through a comprehensive oncology portfolio and an unwavering commitment to excellence powered by a team of dedicated experts.
Fort Myers, Florida, US
Public
$628.2M Revenue
http://www.neogenomics.com
1.9K Employees
NEO Ticker
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment.
South San Francisco, California, US
Public
$250.6M Revenue
https://www.veracyte.com
791 Employees
VCYT Ticker
Top Central ADN Employees
-
Carlos Guzmán Casanova
Director comercial at Central ADN
Ecatepec de Morelos, Méx., MX31 -
José Alfredo Esteban Ponciano
Supervisor de operaciones at Central ADN
Mexico City, CDMX, MX2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
